Clostridium difficile infection is a growing problem in inpatient healthcare facilities and can lead to extended hospital stays, poor patient outcomes and occasionally death.
This document is a practical tool to assist care providers to follow best practice, evidence based processes for prevention, surveillance, and diagnosis.
This guidance was developed with input from the Healthcare Associated Infections Governance Group (HAIGG) whose membership extends across the health sector. The guidance draws on national and international evidence.